The relationship between vitamin D status and abdominal aortic aneurysm (AAA) has not been clearly defined. We conducted an observational study and found an inverse relationship between 25-hydroxyvitamin D (25(OH) D) and the presence of AAA in community-dwelling older men. There is also a negative doseeresponse association between 25(OH)D and the size of AAA, suggesting a role of vitamin D in the severity of aneurysmal arterial disease. To our knowledge, this is the first study to demonstrate an independent relationship between hypovitaminosis D with the presence and size of AAA in older men. Further research is needed to clarify the mechanisms underlying these associations. 
Vitamin D and its metabolites are known to have significant roles in the maintenance of calcium and bone homeostasis. In recent years, they have also been extensively researched for their pleiotropic effects on biological processes other than skeletal health. Epidemiological studies have suggested that hypovitaminosis D might be a contributory factor to cardiovascular disease (CVD) including ischaemic heart disease, peripheral arterial disease (PAD) and stroke. 1 It is also linked to major traditional CVD risk factors, such as hypertension, dyslipidaemia and obesity, 2 as well as CVD mortality. 3 Postulated mechanisms for these presumed cardiovascular effects include endothelial dysfunction, inflammation, reduced vessel compliance, detrimental effects via bone proteins such as osteoprotegerin as well as dysregulation of the renineangiotensin system. 4e8 On the other hand, a recent systematic review and meta-analysis of vitamin D intervention trials failed to demonstrate a significant reduction in CVD events with vitamin D supplementation, thus implying that hypovitaminosis D might be an epiphenomenon, rather than as an aetiological factor for CVD. 9 Aneurysmal arterial disease is pathologically characterised by extensive disruption of the extracellular matrix with the loss of medial elastin and consequent reduction in tensile strength. 10 This results in vascular wall weakening and progressive localised dilatation. Abdominal aortic aneurysm (AAA) and occlusive CVD share many risk factors, including age, male gender, genetic predisposition, smoking, hypertension, hypercholesterolaemia and obesity. 11, 12 As AAA is also independently associated with a higher risk of incident CVD events and mortality, it has been traditionally considered as a manifestation of atherosclerosis. 13 However, there are important differences between aneurysmal and occlusive CVD suggesting disparate pathogenesis. The most notable difference is the inverse association between diabetes and AAA. 14 Vitamin D influences a range of molecular pathways of potential relevance to the pathogenesis of AAA. 15 As the relationship between vitamin D status and AAA is unknown, we sought to determine whether there is any relationship between plasma concentration of vitamin D and both the presence and diameter of AAA. This was undertaken in a large cohort of men aged 70e88 years.
SUBJECTS AND METHODS

Study design and participants
We conducted a cross-sectional observational study of participants from the Health in Men Study (HIMS), which has been described in detail elsewhere. 16, 17 In brief, approximately 40,000 men aged 65e83 years were randomised to the screening and control arms of the trial of screening for AAA. A total of 12,203 men participated in screening and completed a health assessment between 1996 and 1999 (HIMS Wave 1). In 2001e2004, 5585 men responded to the second phase of this study (HIMS Wave 2) and blood samples were collected from 4249 of them. The Human Research Ethics Committee of the University of Western Australia approved the protocol for HIMS and informed consent was obtained from the participants.
Outcome of interest
The abdominal aortic diameter was measured during HIMS Wave 1. The greatest transverse and antero-posterior diameter of the infrarenal aorta was measured using a Toshiba Capasee ultrasound machine with a 3.75-MHz probe (Toshiba Australia, North Ryde, New South Wales, Australia). The reproducibility of these ultrasound measurements has been previously reported. 18 An AAA was considered present if the abdominal aortic diameter was 30 mm or greater.
Explanatory variables
Using a combination of data collected at Waves 1 and 2, the following variables were available: age, smoking status (current, former or never smoker during Wave 2), physical activity (!150 min of moderate-to-vigorous exercise in a usual week during Wave 1), CVD (self-reported history of angina, myocardial infarction, heart failure, coronary artery bypass grafting, coronary angioplasty, carotid endarterectomy, aortic bypass surgery, peripheral arterial surgery or stroke during Wave 1 or 2), hypertension (self-reported diagnosis, or use of anti-hypertensive medications or measured average blood pressure > 140/90 mmHg), diabetes (self-reported diagnosis, or use of glucose-lowering medication, or a fasting glucose of !7 mmol l À1 or non- 19 Body mass index (BMI) was calculated from height and weight in kg m e2 .
Validation of CVD variables
In addition to data from the questionnaire, the Western Australian Data Linkage System (WADLS) 20 was used to identify men with any admissions to hospital for CVD by the end of Wave 2 screening. This system links together data from the state cancer registry, death registry and hospital morbidity data system. The admissions were identified using the relevant diagnoses and procedure codes from the International Classification of Diseases (ICD). The predictive utility of CVD for all-cause mortality was tested in our cohort by using mortality records up to 31 December 2010.
Biochemical analyses
Blood samples were collected during Wave 2 between 0800 and 1030. Plasma was separated from the blood samples within 1 h of collection and stored at À80 C until assayed. The results were reported as odds ratios (ORs) with 95% confidence intervals (95% CI). P-values <0.05 were considered statistically significant.
RESULTS
A flow chart detailing disposition of the study participants is shown in Fig. 1 . Men who had died prior to the Wave 2 followup or did not attend due to various reasons were older in age (P < 0.001), more likely to be smokers (P < 0.001) and self-report a history of CVD (P ¼ 0.025), hypertension (P < 0.001) and diabetes (P < 0.001) during Wave 1, in comparison to those men who subsequently responded in Wave 2. The demographic, clinical and biochemical characteristics of men with and without AAA are shown in Table 1 ), respectively. As many as 311 men (7.4%) had an AAA (aortic diameter !30 mm), 120 men (2.8%) had AAA !35 mm and 66 men (1.6%) had AAA !40 mm. The mean (AESD) aortic diameter for the cohort was 22.8 AE 4.9 mm (range 15.9e79.2 mm).
Predictive utility of CVD for all-cause mortality
In the multivariable Cox proportional hazards model, CVD predicted all-cause mortality (hazard ratio (HR) 1.53, 95% CI 1.36e1.73).
Association of 25(OH)D with AAA
In multivariable logistic regression analysis ( 
Association of 25(OH)D with aortic diameter
We explored the association of 25(OH)D with abdominal aortic diameter by stratifying the aortic diameter into aneurysmal (!30 mm) and non-aneurysmal (<30 mm) ranges ( 
DISCUSSION
In this population-based sample of older men, there is an association between low 25(OH)D concentration and the presence of larger AAA, which is independent of traditional cardiovascular risk factors, and occurs in a graded fashion with increasing sizes of AAA. In men with AAA, 25(OH)D concentration is also inversely correlated with abdominal aortic diameter in a doseeresponse relationship. The strengths of this study include the large sample size of well-characterised, population-based communitydwelling older men. Measurement of the aortic diameter was performed in a standardised procedure using ultrasound. We were able to comprehensively adjust for potential confounders in our multivariable analyses, including age, smoking, CVD and risk factors that have established associations with both vitamin D status and AAA development. We acknowledge several limitations in this study. The observational design of our current study and the fact that blood samples were obtained from the participants several years (5.7 AE 0.9 years) after baseline aortic diameter measurements preclude determination of causality over time. We did not have data on calcium or parathyroid hormone, which can influence vitamin D metabolism. Aortic diameters in our cohort were likely to have increased by a small margin between the period of baseline measurement and blood sampling. 21 However, we have assumed in this study that the small number of interval cases of AAA would not have substantially altered the results or introduced any bias. Those men who had responded for assessment during Wave 2 were younger in age (P < 0.001), more physically active (P < 0.001) and had less self-reported co-morbidities (P < 0.001) during Wave 1 compared to the non-respondents of the follow-up study. The self-selection of participants suggests a possible 'healthy survivor' effect, which might have biased our findings towards higher 25(OH)D concentrations in our cohort compared to the non-respondents. This could have moved the results of our study towards a null hypothesis and led to an underestimation of the association between low 25(OH)D with AAA. Our findings were therefore conservative. The study was limited to men and we were therefore unable to generalise our findings to women, although the prevalence of AAA is about five times greater in men than women. 12 To our knowledge, this is the first study to demonstrate an independent relationship between low vitamin D status with the presence and size of AAA in older men. Van ('severely deficient'), the lack of a control group and the combining of patients with thoracic and abdominal aneurysms make this study inconclusive with regard to the strength and independence of any association between vitamin D status and AAA presence and size. 22 Several previous studies have attempted to explore the relationship between vitamin D status and vascular integrity, which is conceivably impaired in AAA. 23 AAA is characterised by reduced elastin concentration relative to collagen in the aortic wall, 12 also considered to be the pathophysiology in arterial stiffness with reduced vascular compliance. 24 Previous observational studies have associated low vitamin D status with increased arterial stiffness. 5,25e28 Other clinical studies have also reported on the observed association between 25(OH)D and PAD, an alternative model of vascular disease which shares a similar yet distinct pathogenesis with AAA. 1,29e33 Our results extend these findings and further support the relevance of vitamin D to large artery disease in humans.
In experimental studies, 1,25(OH)D binds to the vitamin D receptor and modulates the expression of multiple proteins relevant to the arterial wall, including vascular endothelial growth factor (VEGF) and matrix metalloproteinase type 9 (MMP-9). 15 Vitamin D exerts vasoprotective effects through the inhibition of VEGF-induced endothelial cell proliferation, the anti-proliferative effect on vascular smooth muscle cells (VSMCs) and the suppression of angiogenesis via induction of apoptosis. 34, 35 It also modulates the inflammatory cascade by inhibiting the production of pro-inflammatory cytokines (interleukin-6 and interleukin-8) and the expression of adhesion molecules in human arterial endothelial cells, both of which processes are normally regulated by the activation of nuclear transcription factor-kB (NF-kB) through the induction of tumour necrosis factor alpha (TNF-a). 36 Finally, vitamin D plays a fundamental immune-modulating role by augmenting T-helper 2 cell responses via selective cytokine production, a condition that predominates in AAA formation. 37, 38 Our prevalence of AAA was 7.4%, which was relatively high in comparison to those derived from other large AAA screening programmes. 39 There are a number of possible reasons: men aged up to 83 years, rather than the usual 65e74 years, were included in our study (aortic diameter increases with age), and the fact that measurement of aortic diameter was performed using 'outer to outer' wall (this gives the largest possible diameter).The relatively lower proportions of larger AAAs may be explained by these cases being offered surgery prior to the blood-testing phase of the study. The inverse relationship between diabetes and AAA has been widely reported, albeit inconclusively, due to statistically non-significant findings in some studies. 40 Although we have found a positive association between AAA and the presence of diabetes by the end of Wave 2 screening, a previous analysis using data in Wave 1 reported an inverse correlation between serum glucose and aortic diameter in non-diabetic men.
14 Despite demonstrating seasonal variation in plasma 25(OH)D concentrations, this has not altered the association between low vitamin D status and the presence of larger AAA in our cohort of older men.
In conclusion, we have found an inverse relationship between vitamin D status and the presence of larger AAA, irrespective of traditional CVD and associated risk burden, in community-dwelling older men. There is also an inverse doseeresponse association between 25(OH)D concentrations and the size of AAA, suggesting a role of vitamin D in the severity of aneurysmal arterial disease. Further research is needed to clarify the mechanisms underlying these associations and to explore the feasibility of interventional studies with abdominal aortic diameter as an 'end' point.
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